cancer cancer guidelines clinical trials cancer patients oncology cancer physicians cancer hospitals oncology
NCCN - National Comprehensive Cancer Network National Comprehensive Cancer Network Homepage Patients with Cancer Cancer Clinicians Cancer Industry About National Comprehensive Cancer Network

 

Contact Us / Privacy Policy

About NCCN

NCCN Disclosure of Organizational Relationships

NCCN Resources

Scheduled NCCN Guidelines Panel Meetings

NCCN News

NCCN Leadership

NCCN Employment Opportunities

Permission Requests

NCCN Member Institutions


Contact NCCN


Go back to previous page

 

 

     
 

NCCN wishes to acknowledge the support of the following organizations who share our goal of improving cancer care for patients we serve.

NCCN appreciates that supporting organizations recognize NCCN's need for autonomy in the development of the content of NCCN resources. All NCCN content is produced completely independently. Support from industry is accepted only for distribution of independently developed content.

  • Abbott Laboratories
  • Abraxis BioScience
  • Advanced Health Media, LLC
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Associates of Cape Cod, Inc.
  • Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University
  • AstraZeneca Pharmaceuticals LP
  • Bayer HealthCare Pharmaceuticals Inc.
  • Biogen Idec Inc.
  • BioReference Laboratories, Inc.
  • Blue Cross Blue Shield of Michigan
  • Bristol-Myers Squibb Company
  • BSD Medical Corp.
  • Celgene Corporation
  • Cerner
  • Cephalon, Inc.
  • CIGNA
  • City of Hope
  • Clarient, Inc.
  • Commcare Pharmacy
  • Cytogen Corporation
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • DOR BioPharma, Inc.
  • Duke Comprehensive Cancer Center
  • Endo Pharmaceuticals
  • Eisai Inc.
  • Eli Lilly and Company
  • Elsevier Oncology
  • EMD Healthcare
  • Endo Pharmaceuticals
  • Enzon Pharmaceuticals, Inc.
  • Fox Chase Cancer Center
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • Genentech, Inc.
  • General Electric Healthcare
  • Genomic Health, Inc.
  • Genotpix, Inc.
  • Genzyme Corporation
  • GlaxoSmithKline
  • GPC Biotech
  • H. Lee Moffitt Cancer Center & Research Institute
  • Hospira Worldwide, Inc.
  • Humana
  • Huntsman Cancer Institute at the University of Utah
  • ICU Medical, Inc.
  • ImClone Systems Incorporated
  • IMPAC Medical Systems, Inc.
  • ImpediMed, Inc.
  • Intuitive Surgical, Inc.
  • Jones & Bartlett
  • Medscape
  • Memorial Sloan-Kettering Cancer Center
  • Merck & Co., Inc.
  • MGI PHARMA, INC
  • Millennium Pharmaceuticals, Inc.
  • Myriad Genetics, Inc.
  • National Cancer Institute
  • Northwest Biotherapeutics, Inc.
  • Novartis Pharmaceuticals Corporation
  • Oncology Nursing Society
  • OptumHealth (formerly United Resource Networks)
  • Ortho Biotech Products, L.P.
  • OSI Pharmaceuticals
  • Pfizer Inc.
  • Pharmaid
  • Pharmion Corporation
  • RedPath Integrated Pathology, Inc.
  • Reed Medical Education
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Roche Laboratories, Inc.
  • Roswell Park Cancer Institute
  • sanofi-aventis U.S.
  • Schering-Plough Corporation
  • Sigma-Tau Pharmaceuticals, Inc.
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/University of Tennessee Cancer Institute
  • Stanford Comprehensive Cancer Center
  • Takeda Pharmaceuticals North America, Inc.
  • TAP Pharmaceutical Products Inc.
  • The Binding Site, Inc.
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • The University of Texas M. D. Anderson Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UnitedHealthcare
  • United Resource Networks
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • UNMC Eppley Cancer Center at The Nebraska Medical Center
  • Valeant Pharmaceuticals International
  • Vanderbilt-Ingram Cancer Center
  • Varian Medical Systems
  • Venture Medical Centers
  • Veridex, LLC
  • Vion Pharmaceuticals, Inc.
  • Within3
  • Wyeth Pharmaceuticals

Go back to previous page

 

Educational Opportunities

NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™

September 4, 2008
New York Marriott at the Brooklyn Bridge
New York, New York

NCCN 3rd Annual Congress: Hematologic Malignancies™

September 5 – 6, 2008
New York Marriott at the Brooklyn Bridge
New York, New York


Exhibitor Information


NCCN Regional Guidelines Symposia

NCCN Non-Small Cell Lung Cancer Guidelines Symposium
Birmingham, Michigan (Friday, September 12, 2008)

NCCN Breast Cancer Guidelines Symposium
Durham, North Carolina (Monday, September 22, 2008)

NCCN Colon and Rectal Cancers Guidelines Symposia
New York , New York (Tuesday, September 23, 2008)

NCCN Head and Neck Cancers Guidelines Symposia
Omaha, Nebraska (Friday, October 10, 2008)

NCCN Breast Cancer Guidelines Symposium
Tampa, Florida (Monday, October 20, 2008)

NCCN Non-Small Cell Lung Cancer Guidelines Symposium
Durham, North Carolina (Monday, November 03, 2008)

NCCN Prostate Cancer Guidelines Symposia
Philadelphia, PA (Wednesday, November 05, 2008)

NCCN Head and Neck Cancers Guidelines Symposia
Houston, Texas (Tuesday, November 11, 2008)

More Events ....


NCCN International

Chinese – 中文

Japanese –日本語

NCCN Privacy Policy NCCN Legal Disclaimer NCCN Site Map Contact NCCN Home National Comprehensive Cancer Network